Choice of the most appropriate biological disease-modifying anti-rheumatic drug for injection spacing: results from a multicentre observational study

OBJECTIVESTo determine which biological disease-modifying anti-rheumatic drug (bDMARD) is most appropriate for spacing in patients with rheumatoid arthritis (RA) who have persistent stable symptoms. METHODSIn patients with sustained low disease activity (LDA) or better for ≥3 months who were treated...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical and experimental rheumatology 2020-05, Vol.38 (3), p.398-404
Hauptverfasser:	Matsuno, Hiroaki, Katayama, Kou, Funahashi, Keiko, Saitoh, Makoto, Matsubara, Tsukasa
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!